Financial News

Recent Quotes

My Watchlist

Indicators

Overview

Canopy Growth’s stock falls back from recent gains as cannabis stocks cool off

By: MarketWatch

September 12, 2023 at 13:26 PM EDT

The optimism around a potential rescheduling of cannabis fades as 14 Republican members of Congress say pot should remain a Schedule I drug under federal law.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Canopy Growth’s stock falls back from recent gains as cannabis stocks cool off

Popular Pages